Dávila, B.; Vignolo, P.; Silvarrey, M.; BenÃtez, A.; González Schmidt, J.; de Arteaga Guidotti, C.; GarcÃa, M.F.; Cerecetto, H.; Couto, M.
Structure-Activity Relationships of closo- and nido-Carborane Erlotinib Analogs: Lipophilicity as a Key Modulator of Anti-Glioma Activity. Pharmaceuticals 2025, 18, 1753.
https://doi.org/10.3390/ph18111753
AMA Style
Dávila B, Vignolo P, Silvarrey M, BenÃtez A, González Schmidt J, de Arteaga Guidotti C, GarcÃa MF, Cerecetto H, Couto M.
Structure-Activity Relationships of closo- and nido-Carborane Erlotinib Analogs: Lipophilicity as a Key Modulator of Anti-Glioma Activity. Pharmaceuticals. 2025; 18(11):1753.
https://doi.org/10.3390/ph18111753
Chicago/Turabian Style
Dávila, Belén, Pablo Vignolo, Martina Silvarrey, Andrés BenÃtez, Juliana González Schmidt, Carmela de Arteaga Guidotti, MarÃa Fernanda GarcÃa, Hugo Cerecetto, and Marcos Couto.
2025. "Structure-Activity Relationships of closo- and nido-Carborane Erlotinib Analogs: Lipophilicity as a Key Modulator of Anti-Glioma Activity" Pharmaceuticals 18, no. 11: 1753.
https://doi.org/10.3390/ph18111753
APA Style
Dávila, B., Vignolo, P., Silvarrey, M., BenÃtez, A., González Schmidt, J., de Arteaga Guidotti, C., GarcÃa, M. F., Cerecetto, H., & Couto, M.
(2025). Structure-Activity Relationships of closo- and nido-Carborane Erlotinib Analogs: Lipophilicity as a Key Modulator of Anti-Glioma Activity. Pharmaceuticals, 18(11), 1753.
https://doi.org/10.3390/ph18111753
